Idorsia Pharmaceuticals Ltd (IDRSF) Q2 2024 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good day and thank you for standing by. Welcome to the Eidosia Half-Year 2024 Financial Results webcast. At this time, all participants are in listen-only mode. After the speaker's presentation, there will be the question and answer session. To ask a question during the session, you need to press star 11 on your telephone keypad. You will then hear an automated message advising your hand is raised. To withdraw a question, please press star 11 again. Please be advised that today's conference is being recorded. I would now like to hand the conference over to our speaker today, Andrew Weiss. Please go ahead. Thank you, Nadia. Good afternoon. Good morning to you all. My name is Andrew Weiss. I'm the head of investor relations and corporate communications here at Adorsia. And welcome to our webcast conference call to discuss our first half results 2024 today. On the call are our CEO, Andre Muller, and our chief financial officer, Arno Grunewald. who are both with me for the first time in their new roles to give you additional color on what we announced this morning. Then, for the Q&A session, we will have our General Manager and President of IDORSA US, Tosh Butt, and our President of the IDORSA UCAN region, Benjamin Limal. Next slide, please. Before handing over the microphone, I need to remind everyone that we will be making forward-looking statements. You have therefore been appropriately warned about the risks and opportunities of investing in Eidosia shares. With that, I hand over to André for his introductory remarks. Next slide. Thank you, Andrew. Good afternoon. Good morning, everyone. Chris, 11 years at Actelion in Eidosia. I had several opportunities to be presenting to you, but actually it's the first time as CEO of Eidosia. So it's good to be back on regular re...